- Breast Cancer Drug Eribulin Extends Survival
The new breast cancer drug eribulin (Halaven) extends survival two and a half months longer than other therapies for advanced breast cancer, researchers report....
- Targeted Breast Cancer Drug Shrinks Tumors
A new targeted cancer drug called T-DM1 has been shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, failed....
- Bone Drug May Extend Lives of Young Women With Breast Cancer
A drug given to protect bones during breast cancer treatment extended the lives of young women with the disease, researchers report....
- Nexavar May Treat Advanced Breast Cancer
Adding the cancer drug Nexavar to standard chemotherapy significantly extends the time until advanced breast cancer progresses, researchers report....
- Experimental Drug Shrinks Breast Tumors
An experimental drug can slash the number of chemotherapy-resistant cancer stem cells in women with advanced breast cancer, curbing tumor growth, researchers report....
- FDA Mulls Fate of Avastin as Breast Cancer Drug
The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....
- FDA Mulls Fate of Avastin as Breast Cancer Drug
The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....
- FDA Mulls Fate of Avastin as Breast Cancer Drug
The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....
- FDA Mulls Fate of Avastin as Breast Cancer Drug
The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....
- Breast Cancer Drug Fights Lung Cancer, Too
The anti-hormone drug tamoxifen, which is used to treat breast cancer, may also reduce the risk of dying from lung cancer, a study of over 6,000 women suggests....
- Sea Sponge Drug May Fight Breast Cancer
A drug derived from sea sponges extended the lives of breast cancer patients whose cancer had come back -- despite as many as five rounds of chemotherapy -- by an average of two and a half months....
- Bone Drug Fails in Breast Cancer Study
The bone-building drug Zometa does not appear to prevent breast cancer from coming back in most women, researchers report....
- Drug May Be New Option to Cut Breast Cancer Risk
Women over age 60 can safely take an estrogen-lowering drug to reduce their risk of getting breast cancer, a new study shows....
- Less Toxic Treatment for Aggressive Breast Cancers?
A new study shows that a shorter, less toxic chemotherapy regimen that includes the drug Herceptin appears to be just as effective in women with HER-2 positive breast cancer as using a standard three-drug therapy with Herceptin, a strategy that can be harder on the heart....
- Drug Extends Prostate Cancer Survival
Even when medical or surgical castration fails, a potent drug extends survival by 4 months in patients with metastatic prostate cancer....
- FDA Panel Opposes Avastin for Breast Cancer
An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....
- FDA Panel Opposes Avastin for Breast Cancer
An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....
- FDA Panel Opposes Avastin for Breast Cancer
An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....
- FDA Panel Opposes Avastin for Breast Cancer
An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....
- Bone Drug May Prevent Return of Breast Cancer
A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....
- Bone Drug May Prevent Return of Breast Cancer
A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....
- Bone Drug May Prevent Return of Breast Cancer
A drug that battles bone loss may have added benefits for women with estrogen-sensitive breast cancers, significantly reducing the chance that their cancer will return or spread, a new study shows....
- Drug Combo Wipes Out Tumor Cells
Giving a combination of the targeted drugs Herceptin and Tykerb before breast cancer surgery wipes out tumor cells in about twice as many women as either drug alone....
- Drug Combo Wipes Out Tumor Cells
Giving a combination of the targeted drugs Herceptin and Tykerb before breast cancer surgery wipes out tumor cells in about twice as many women as either drug alone....
- New Treatments Target Advanced Breast Cancer
Women with advanced breast cancer may soon have two new treatment options that target the disease's roots....
- Herceptin: Long-Term Benefits for Breast Cancer
High-risk breast cancer patients continue to derive benefits from the drug Herceptin even four years after stopping treatment, but questions remain about the biologic therapy’s safety when given with chemotherapy....
- Seizure Drug May Extend Lives of Brain Cancer Patients
When added to standard treatment, an older seizure drug called valproic acid may extend the lives of people with brain cancer by an average of three months, a study shows....
- Tamoxifen, Evista Prevent Breast Cancer
Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women....
